Physician profile
Seth H Baker
NPI 1447225214
$3,924.90
in general payments reported to CMS, 2019-2025
36 companies · $746 in 2025
The $746 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $445 · 2021: $326 · 2022: $861 · 2023: $783 · 2024: $524 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,052.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $540.25 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $449.59 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $279.82 | 2022-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $278.99 | 2020-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $258.30 | 2021-2024 | Eliquis, Camzyos |
| Boston Scientific Corporation | $256.68 | 2019-2025 | Watchman Flx |
| Amgen INC. | $228.92 | 2021-2025 | Repatha, Repatha |
| Cvrx, INC. | $216.57 | 2023-2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $154.53 | 2020 | |
| Sanofi-Aventis U.S. LLC | $133.55 | 2021-2024 | |
| Novo Nordisk INC | $93.42 | 2021-2025 | Ozempic |
| Lexicon Pharmaceuticals, INC. | $92.37 | 2023-2024 | Inpefa |
| United Therapeutics Corporation | $84.62 | 2023-2024 | Tyvaso |
| Kiniksa Pharmaceuticals, LTD. | $78.37 | 2021-2023 | Arcalyst |
| Abbott Laboratories | $62.57 | 2022-2024 | Amplatzer Talisman |
Show all 34 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.